Sintx Technologies (SINT) Stock Price, News & Analysis

Company Overview

Sintx Technologies, Inc., an advanced ceramics company, engages in the research, development, and commercialization of medical devices manufactured with silicon nitride for biomedical, technical, and antipathogenic applications in the United States. It provides solid and porous silicon nitride; silicon nitrite powder; and silicon nitride coating products, as well as silicon nitride composite materials, polyetheretherketone, and polyetherketoneketone. The company was formerly known as Amedica Corporation. Sintx Technologies, Inc. was incorporated in 1996 and is headquartered in Salt Lake City, Utah.

Key Stats

• Today's Range: $2.73 to $2.89
• 50-Day Range: $1.73 to $3.45
• 52-Week Range: $1.71 to $8.60
• Volume: 23,088 shs
• Average Volume: 937,718 shs
• Market Capitalization: $7.14 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: $28.00
• Consensus Rating: Buy

Sintx Technologies Stock Analysis - MarketRank™

Sintx Technologies scored higher than 53% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 3.5 / 5
• Analyst Rating: Buy

Consensus Rating

Sintx Technologies has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 1 buy rating, no hold ratings, and no sell ratings.

Amount of Analyst Coverage

Sintx Technologies has only been the subject of 1 research reports in the past 90 days.

Earnings and Valuation

• Score: 0.6 / 5
• Proj. Earnings Growth: N/A

Price to Earnings Ratio vs. the Market

The P/E ratio of Sintx Technologies is -0.06, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Earnings Ratio vs. Sector

The P/E ratio of Sintx Technologies is -0.06, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Book Value per Share Ratio

Sintx Technologies has a P/B Ratio of 0.01. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

Short Interest

• Score: 5.0 / 5
• Short Interest Level: Healthy

Percentage of Shares Shorted

4.35% of the float of Sintx Technologies has been sold short.

Short Interest Ratio / Days to Cover

Sintx Technologies has a short interest ratio ("days to cover") of 0.5, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Sintx Technologies has recently decreased by 11.68%, indicating that investor sentiment is improving significantly.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

Sintx Technologies does not currently pay a dividend.

Dividend Growth

Sintx Technologies does not have a long track record of dividend growth.

Sustainability and ESG

• Score: N/A
• Environmental Score: N/A

Percentage of Shares Shorted

4.35% of the float of Sintx Technologies has been sold short.

Short Interest Ratio / Days to Cover

Sintx Technologies has a short interest ratio ("days to cover") of 0.5, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Sintx Technologies has recently decreased by 11.68%, indicating that investor sentiment is improving significantly.

News and Social Media

• Score: 0.7 / 5
• News Sentiment: N/A

News Sentiment

Sintx Technologies has a news sentiment score of -0.67. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.70 average news sentiment score of Medical companies.

News Coverage This Week

MarketBeat has tracked 1 news article for Sintx Technologies this week, compared to 1 article on an average week.

Company Ownership

• Score: 1.7 / 5
• Insider Trading: Acquiring Shares

Insider Buying vs. Insider Selling

In the past three months, Sintx Technologies insiders have bought more of their company's stock than they have sold. Specifically, they have bought $29,908.00 in company stock and sold $0.00 in company stock.

Percentage Held by Insiders

Only 0.01% of the stock of Sintx Technologies is held by insiders.

Percentage Held by Institutions

Only 18.38% of the stock of Sintx Technologies is held by institutions.

SINT Stock Analysis - Frequently Asked Questions

How have SINT shares performed this year?

Sintx Technologies' stock was trading at $3.50 at the beginning of the year. Since then, SINT stock has decreased by 20.3% and is now trading at $2.79.
View the best growth stocks for 2025 here.

How were Sintx Technologies' earnings last quarter?

Sintx Technologies, Inc. (NASDAQ:SINT) posted its quarterly earnings data on Thursday, May, 15th. The company reported ($1.29) EPS for the quarter, missing the consensus estimate of ($0.71) by $0.58. The company earned $0.37 million during the quarter, compared to the consensus estimate of $0.73 million. Sintx Technologies had a negative trailing twelve-month return on equity of 140.68% and a negative net margin of 358.79%.

When did Sintx Technologies' stock split?

Sintx Technologies shares reverse split on the morning of Tuesday, May 28th 2024. The 1-200 reverse split was announced on Tuesday, May 28th 2024. The number of shares owned by shareholders was adjusted after the closing bell on Tuesday, May 28th 2024. An investor that had 100 shares of stock prior to the reverse split would have 1 shares after the split.

Who are Sintx Technologies' major shareholders?

Top institutional investors of Sintx Technologies include Heights Capital Management Inc. (2.42%). Insiders that own company stock include Gregg R Honigblum, Mark Lewis Anderson, Eric K Olson and David W Truetzel.
View institutional ownership trends.

How do I buy shares of Sintx Technologies?

Shares of SINT stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of Sintx Technologies own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Sintx Technologies investors own include Bionano Genomics (BNGO), Sorrento Therapeutics (SRNE), NightHawk Biosciences (NHWK), NIO (NIO), Citius Pharmaceuticals (CTXR), T2 Biosystems (TTOO) and Boxlight (BOXL).

Company Calendar

• Last Earnings: 5/15/2025
• Today: 6/06/2025
• Next Earnings (Estimated): 8/04/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Medical
• Industry: Surgical & medical instruments
• Sub-Industry: Medical Equipment
• Current Symbol: NASDAQ:SINT
• CIK: 1269026
• Web: www.sintx.com
• Phone: (855) 839-3500
• Fax: N/A
• Employees: 40
• Year Founded: N/A

Price Target and Rating

• Average Stock Price Target: $28.00
• High Stock Price Target: $28.00
• Low Stock Price Target: $28.00
• Potential Upside/Downside: +903.6%
• Consensus Rating: Buy
• Rating Score (0-4): 3.00
• Research Coverage: 1 Analysts

Profitability

• EPS (Most Recent Fiscal Year): ($50.56)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: -$8.26 million
• Net Margins: -358.79%
• Pretax Margin: -358.79%
• Return on Equity: -140.68%
• Return on Assets: -78.29%

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 3.04
• Quick Ratio: 2.82

Sales & Book Value

• Annual Sales: $1.23 million
• Price / Sales: 5.70
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: $329.74 per share
• Price / Book: 0.01

Miscellaneous

• Outstanding Shares: 2,509,000
• Free Float: 1,343,000
• Market Cap: $7.00 million
• Optionable: Not Optionable
• Beta: 0.82